Thursday, December 5, 2024
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
PRESENTING FACULTY
 |
Dr. Stephen Salloway Martin M. Zucker Professor of Psychiatry and Human Behavior Professor of Neurology The Warren Alpert Medical School of Brown University Associate Director, Brown University Center for Alzheimer’s Disease Research Providence, RI |
PROGRAM DESCRIPTION
The planned innovative series intends to help healthcare providers improve their understanding of the burden of early Alzheimer’s disease on patients and caregivers; highlight the value of collaborating with a multidisciplinary team to determine the best practices for diagnosis of early Alzheimer’s disease; review new and ongoing clinical trials on disease-modifying therapy of early Alzheimer’s disease. This program will also outline the maintenance dosing of disease-modifying treatment and assess the risk of imaging abnormalities associated with the management of Alzheimer’s disease with anti-amyloid therapy.
TARGET AUDIENCE
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including Alzheimer’s disease specialists, neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
LEARNING OBJECTIVES
- Describe the burden of early Alzheimer’s disease on patients and caregivers
- Evaluate best practices in the diagnosis of early Alzheimer’s disease through multidisciplinary specialty collaboration
- Summarize current clinical data informing the use of disease-modifying therapy in the management of early Alzheimer’s disease
- Discuss the potential need for continued and maintenance dosing of disease-modifying therapies in early Alzheimer’s disease
- Assess the risk of ARIA in the management of Alzheimer’s disease with anti-amyloid therapy
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
